All Baxalta Us Inc Sponsors for H1B Applications - 2015

Explore H1B salary data for top companies like Baxalta-us-inc across different cities for various job titles and discover the average salaries.

Company name
Job Title
City Name
Average Salary
Baxalta Us Inc Senior Clinical Programmer Analyst Deerfield $ 94,898 / Year
Baxalta Us Inc Senior Manager Clinical Systems Deerfield $ 137,280 / Year
Baxalta Us Inc Critical Systems Engineer Ii Deerfield $ 73,897 / Year
Baxalta Us Inc Senior Clinical Programmer Analyst Deerfield $ 94,898 / Year
Baxalta Us Inc Manager Regulatory Affairs Deerfield $ 130,000 / Year
Baxalta Us Inc Senior Manager Business Projects Deerfield $ 145,000 / Year
Baxalta Us Inc Sr Mgr Medical Outcomes Research And Economics More Deerfield $ 158,000 / Year
Baxalta Us Inc Senior Principal Engineer Deerfield $ 134,722 / Year
Baxalta Us Inc Quality Control Analyst Ii Deerfield $ 53,717 / Year
Baxalta Us Inc Director Validation Deerfield $ 164,436 / Year
Baxalta Us Inc Clinical Programmer Analyst Ii Deerfield $ 89,009 / Year
Baxalta Us Inc Clinical Programmer Analyst Ii Deerfield $ 96,000 / Year
Baxalta Us Inc Principal Engineer Deerfield $ 93,556 / Year
Baxalta Us Inc Senior Engineer Deerfield $ 87,543 / Year
Baxalta Us Inc Senior Principal Engineer Deerfield $ 118,644 / Year
Baxalta Us Inc Director Heor Latin America Deerfield $ 160,000 / Year
Baxalta Us Inc Technical Specialist Deerfield $ 91,530 / Year
Baxalta Us Inc Senior Datastage Developer Deerfield $ 108,742 / Year
Baxalta Us Inc Engineer Ii Deerfield $ 75,398 / Year
Baxalta Us Inc Research Associate Ii Deerfield $ 65,000 / Year

Last 5 Years H-1B Salary Data

h1bInfo.org is an independent website that displays public disclosure data in a user-friendly format. We have analyzed 10 years of H1B data from USCIS and the US Department of Labor, covering more than 6 million records from FY 2014 to FY 2023. However, for the latest and most accurate data, it's best to check the official sources directly. All content on H1BInfo is copyrighted and all rights are reserved from 2022 to 2023.